Home / News / Quick-Med licenses Stay Fresh technology to Medline

Quick-Med licenses Stay Fresh technology to Medline

01 Mar '14
2 min read

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced that it has licensed its Stay Fresh technology to Medline Industries, Inc. for use in traditional wound care products for both retail and institutional sale in the North American market.
 
"We are very excited to work together with Medline to commercialize our Stay Fresh technology for the traditional wound care market," said Bernd Liesenfeld, Quick-Med's President. "Our technologies are specifically designed to be effective against resistant organisms like MRSA and to prevent new resistant bacteria from emerging. 
 
Medline has an unparalleled distribution network between retail and institutional sectors. They allow us together to provide the greatest possible population with safe, effective antimicrobial products in support of infection prevention and control programs."
 
"Stay Fresh antimicrobial activity is based on peroxide, which is the chemical mechanism utilized by the body's own neutrophils to kill invading pathogens, and therefore provides optimum biological safety," notes Professor Gregory Schultz, Director of the Institute for Wound Research and Professor of Obstetrics and Gynecology at the University of Florida. 
 
"This is an exciting new technology that is well suited for the traditional wound care field since peroxide is effective against a broad array of microbes, including antibiotic resistant species of public health importance, while also posing little risk of allowing microbes to develop resistance to it." 
 
About Stay Fresh
The patented Stay Fresh technology is Quick-Med's newest antimicrobial platform. This technology is based on hydrogen peroxide -- a well known consumer antimicrobial product that is commonly used in households for disinfecting cuts, scrapes, toothbrushes and more. Hydrogen peroxide is also produced by human cells to combat invasive bacteria, and is a naturally occurring preservative component of milk and honey. 
 
EPA has registered Stay Fresh to be utilized to protect a broad selection of treated goods for consumer use, including textiles, decorative fabrics, and functional fabrics such as filters and carpets. FDA has also granted clearance to market an antibacterial medical textile based on Stay Fresh Technology.
 
The Stay Fresh technology offerings provided by Quick-Med are expanding continuously with development of additional applications, including antimicrobial surface treatments and superabsorbent antimicrobial powders to complement the range of products that are already cleared for consumer use under EPA or FDA jurisdiction.

Quick-Med Technologies

Leave your Comments

FICCI urges formulating technical textile standards
FICCI urges formulating technical textile standards
Celanese hikes EMEA region vinyl acetate emulsions price
Celanese hikes EMEA region vinyl acetate emulsions price

Follow us